Please login to the form below

Not currently logged in
Email:
Password:

Biogen's Douglas Williams departs for biotech start-up

Research head will be first member of a new cancer-focused firm

Biogen Douglas WilliamsDouglas Williams will this week leave Biogen for a new role as CEO of an as-yet unnamed biotech start-up that will focus on cancer diagnostics and therapies.

Williams had led Biogen's R&D  since 2011 as executive vice president of research and development, prior to which his industry roles included a six year stint at Seattle-based biotech Zymogenetics (now part of BMS), where he rose to be its CEO.

He said: “While I am sad to leave Biogen I am excited about the opportunity to follow a real passion of mine. I am proud of the progress of the company's R&D organisation and am pleased that it will be in very capable hands.”

Williams will be replaced by chief medical officer Alfred Sandrock and chief scientific officer Spyros Artavanis-Tsakonas, who will be handed joint responsibility for Biogen Research and Development.

Biogen's CEO George Scangos said: “All of us at Biogen appreciate Doug's contributions to the rapid development of our Research and Development organisation.

“We are fortunate to have Al Sandrock and Spyros Artavanis-Tsakonas to lead the work to which Biogen is dedicated.”

27th July 2015

From: Research

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

New from the PhRMA: Diversity in clinical trials principles summarised
In November 2020, PhRMA announced the first-ever, industry-wide principles on clinical trial diversity. The principles were approved by the PhRMA Boards of Directors and will take effect in April 2021....
New from the FDA: Diversity in clinical trials guidance summarised
In November 2020, the FDA released guidance to enable greater diversity in clinical trials through changes to eligibility criteria, enrolment practices, and trial designs....
5 steps to effective clinical trial branding
When recruiting patients for your clinical trial, you want the materials and information around it to be seen as reputable and professional. To make it clear what the clinical trial...

Infographics